Literature DB >> 28718404

Emerging Role of the Unfolded Protein Response in Tumor Immunosurveillance.

Hélène Vanacker1, Jessica Vetters2, Lyvia Moudombi1, Christophe Caux1, Sophie Janssens2, Marie-Cécile Michallet3.   

Abstract

Disruption of endoplasmic reticulum (ER) homeostasis results in ER stress and activation of the unfolded protein response (UPR). This response alleviates cell stress, and is activated in both tumor cells and tumor infiltrating immune cells. The UPR plays a dual function in cancer biology, acting as a barrier to tumorigenesis at the premalignant stage, while fostering cancer maintenance in established tumors. In infiltrating immune cells, the UPR has been involved in both immunosurveillance and immunosuppressive functions. This review aims to decipher the role of the UPR at different stages of tumorigenesis and how the UPR shapes the balance between immunosurveillance and immune escape. This knowledge may improve existing UPR-targeted therapies and the design of novel strategies for cancer treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer; immune cells; immune escape; immunosurveillance; unfolded protein response

Mesh:

Substances:

Year:  2017        PMID: 28718404     DOI: 10.1016/j.trecan.2017.05.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  17 in total

Review 1.  Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity.

Authors:  Xiaodan Qin; William D Denton; Leah N Huiting; Kaylee S Smith; Hui Feng
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-07-07       Impact factor: 8.250

2.  Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.

Authors:  Xiaoming Wang; Yunjin Bai; Facai Zhang; Yubo Yang; Dechao Feng; Ao Li; Zhiqiang Yang; Dengxiong Li; Yin Tang; Xin Wei; Wuran Wei; Ping Han
Journal:  Onco Targets Ther       Date:  2020-09-28       Impact factor: 4.147

3.  Unfolded Protein Response-Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma.

Authors:  Zhao Zhang; Xincheng Liu; Debin Cheng; Jingyi Dang; Zhenzhou Mi; Yubo Shi; Lei Wang; Hongbin Fan
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

4.  Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases.

Authors:  Arnaud Pommier; Naishitha Anaparthy; Nicoletta Memos; Z Larkin Kelley; Alizée Gouronnec; Ran Yan; Cédric Auffray; Jean Albrengues; Mikala Egeblad; Christine A Iacobuzio-Donahue; Scott K Lyons; Douglas T Fearon
Journal:  Science       Date:  2018-05-17       Impact factor: 47.728

Review 5.  Transcriptomic Profiling of MDA-MB-231 Cells Exposed to Boswellia Serrata and 3-O-Acetyl-B-Boswellic Acid; ER/UPR Mediated Programmed Cell Death.

Authors:  Elizabeth A Mazzio; Charles A Lewis; Karam F A Soliman
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

Review 6.  Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy.

Authors:  Sheera R Rosenbaum; Nicole A Wilski; Andrew E Aplin
Journal:  Cancer Discov       Date:  2021-01-15       Impact factor: 38.272

Review 7.  Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity.

Authors:  Yoon Seon Yoo; Hye Gyeong Han; Young Joo Jeon
Journal:  Oxid Med Cell Longev       Date:  2017-12-21       Impact factor: 6.543

Review 8.  Hypoxic Signalling in Tumour Stroma.

Authors:  Anu Laitala; Janine T Erler
Journal:  Front Oncol       Date:  2018-05-29       Impact factor: 6.244

Review 9.  Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance.

Authors:  Megha Budhwani; Roberta Mazzieri; Riccardo Dolcetti
Journal:  Front Oncol       Date:  2018-08-21       Impact factor: 6.244

Review 10.  Protein Quality Control in the Endoplasmic Reticulum and Cancer.

Authors:  Hye Won Moon; Hye Gyeong Han; Young Joo Jeon
Journal:  Int J Mol Sci       Date:  2018-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.